The traditional classification into type 1 and type 2 diabetes has proven useful in differentiating distinct pathophysiological mechanisms with clear therapeutic implications. However, it remains insufficient in explaining the wide variety of clinical manifestations of this disease. Recent developments involve the use of precision medicine in diabetes. These advances along with artificial intelligence are aiming to assist physicians in dealing with this lifestyle disorder.
In this video, Dr. Unnikrishnan briefs on the International Diabetes Summit (IDS) to be held in March 2019 at Chellaram Diabetes Institute (CDI), Pune, Maharashtra, India. The summit will cover various topics like: Low-carb diet for diabetes reversal Newer drugs for diabetes and heart failure treatment Diabetic kidney disease Role of precision medicine in diabetes Role of Artificial Intelligence (AI) in diabetes To…
